HR 1300
104th Congress
House
FDA Export Reform and Enhancement Act of 1995
Official title: To amend the Federal Food, Drug, and Cosmetic Act to authorize the export of new drugs, and for other purposes.
Health
Agriculture and FoodAnimalsCommerceDrug industry
More subjectsShow fewer subjects
DrugsExport controlsExportsFood adulteration and inspectionForeign Trade and International FinanceGovernment Operations and PoliticsGovernment paperworkImportsLabelingMedical suppliesProduct safetyVeterinary medicine
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 10, 1995
Referred to the Subcommittee on Health and Environment.
Mar 22, 1995
Referred to the House Committee on Commerce.
Mar 22, 1995
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Latest action
Referred to the Subcommittee on Health and Environment.
Plain-English summary
FDA Export Reform and Enhancement Act of 1995 - Amends the Federal Food, Drug, and Cosmetic Act (FDCA) to modify the circumstances in which a drug, device, or biological product (including a partially processed biological product) may be exported.
Bill text
1 version
- Introduced in House Formatted Text PDF
Committees of jurisdiction
2
Cite this page
U.S. Congress. (2026). H.R. 1300: FDA Export Reform and Enhancement Act of 1995. 104th Congress. Open America. https://openamerica.io/bill/104-HR-1300/
"H.R. 1300: FDA Export Reform and Enhancement Act of 1995." 104th Congress, 2026, Open America, https://openamerica.io/bill/104-HR-1300/.
H.R. 1300, 104th Cong. (2026), https://openamerica.io/bill/104-HR-1300/.
[H.R. 1300: FDA Export Reform and Enhancement Act of 1995](https://openamerica.io/bill/104-HR-1300/)